Metabolic syndrome and breast cancer survivors: a follow-up analysis after completion of chemotherapy

BACKGROUND: We previously reported that (neo)adjuvant chemotherapy adversely altered metabolic syndrome (MetS) components, body composition, and related biomarkers after a 12 to 18-week chemotherapy treatment course in women. Here, we sought to determine whether these measures worsened within 4–5 ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Dieli-Conwright, Christina M., Wong, Louise, Waliany, Sarah, Mortimer, Joanne E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895575/
https://www.ncbi.nlm.nih.gov/pubmed/35241143
http://dx.doi.org/10.1186/s13098-022-00807-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895575/
https://www.ncbi.nlm.nih.gov/pubmed/35241143
http://dx.doi.org/10.1186/s13098-022-00807-y

Ejemplares similares